ETFChannel.com
PRCT Description — PROCEPT BioRobotics Corp

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. Co. develops, manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). BPH is a common prostate disease. The AquaBeam Robotic System employs a single-use disposable handpiece to deliver Co.'s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted removal of prostate tissue.

Company Name: 
PROCEPT BioRobotics Corp
Website: 
www.procept-biorobotics.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding PRCT: 
27
Total Market Value Held by ETFs: 
$310,350,455.51
Total Market Capitalization: 
$2,650,000,000
% of Market Cap. Held by ETFs: 
11.71%
 ETF   PRCT Weight   PRCT Amount 
 VTI   0.00%   $68,860,176         
 VB   0.04%   $56,034,467         
 IWM   0.08%   $49,336,886         
 VXF   0.03%   $33,875,417         
 VBK   0.09%   $31,705,225         
 IWO   0.17%   $17,826,133         
 IHI   0.29%   $15,204,031         
 VHT   0.04%   $7,917,202         
 VTWO   0.08%   $7,706,668         
 KOMP   0.26%   $4,707,028         
List of all 27 ETFs holding PRCT »
Quotes delayed 20 minutes

Email EnvelopeFree PRCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.75 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding PRCT | PROCEPT BioRobotics Corp | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.